COVID-19 Impact on Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Peptide Receptor Radionuclide Therapy (PRRT) Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Gastroenteropancreatic Neuroendocrine Tumor
  • 1.4.3 Foregut Neuroendocrine Tumor
  • 1.4.4 Midgut Neuroendocrine Tumor
  • 1.4.5 Hindgut Neuroendocrine Tumor
• 1.5 Market by Application
  • 1.5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital Pharmacies
  • 1.5.3 Retail Pharmacies
  • 1.5.4 Online Pharmacies
• 1.6 Coronavirus Disease 2019 (Covid-19): Peptide Receptor Radionuclide Therapy (PRRT) Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Peptide Receptor Radionuclide Therapy (PRRT) Industry
    • 1.6.1.1 Peptide Receptor Radionuclide Therapy (PRRT) Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Peptide Receptor Radionuclide Therapy (PRRT) Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Peptide Receptor Radionuclide Therapy (PRRT) Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Perspective (2015-2026)
• 2.2 Peptide Receptor Radionuclide Therapy (PRRT) Growth Trends by Regions
  • 2.2.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Peptide Receptor Radionuclide Therapy (PRRT) Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Market Size
  • 3.1.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue (2015-2020)
  • 3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio
  • 3.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2019
• 3.3 Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Area Served
• 3.4 Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product Solution and Service
• 3.5 Date of Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Type (2015-2020)
• 4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2021-2026)

5 Peptide Receptor Radionuclide Therapy (PRRT) Breakdown Data by Application (2015-2026)

• 5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)
• 5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
• 6.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in North America (2019-2020)
• 6.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
• 6.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
• 7.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Europe (2019-2020)
• 7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
• 7.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

8 China

• 8.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
• 8.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in China (2019-2020)
• 8.3 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
• 8.4 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
• 9.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Japan (2019-2020)
• 9.3 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
• 9.4 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
• 10.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
• 10.4 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

11 India

• 11.1 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
• 11.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in India (2019-2020)
• 11.3 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
• 11.4 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
• 12.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
• 12.4 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Novartis
  • 13.1.1 Novartis Company Details
  • 13.1.2 Novartis Business Overview and Its Total Revenue
  • 13.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Introduction
  • 13.1.4 Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020))
  • 13.1.5 Novartis Recent Development
• 13.2 ITM Solucin
  • 13.2.1 ITM Solucin Company Details
  • 13.2.2 ITM Solucin Business Overview and Its Total Revenue
  • 13.2.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Introduction
  • 13.2.4 ITM Solucin Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
  • 13.2.5 ITM Solucin Recent Development
• 13.3 National Institutes of Health
  • 13.3.1 National Institutes of Health Company Details
  • 13.3.2 National Institutes of Health Business Overview and Its Total Revenue
  • 13.3.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Introduction
  • 13.3.4 National Institutes of Health Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
  • 13.3.5 National Institutes of Health Recent Development
• 13.4 Australasian Gastro-Intestinal Trials Group
  • 13.4.1 Australasian Gastro-Intestinal Trials Group Company Details
  • 13.4.2 Australasian Gastro-Intestinal Trials Group Business Overview and Its Total Revenue
  • 13.4.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Introduction
  • 13.4.4 Australasian Gastro-Intestinal Trials Group Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
  • 13.4.5 Australasian Gastro-Intestinal Trials Group Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer